Khaled M Musallam

32PUBLICATIONS
48CO-AUTHORS
HaematologyHaematological tumoursGene and molecular therapyEpidemiological methodsNanotoxicology, health and safety
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (32)

|Jul 09, 2026
Thalassaemia.

|Jun 09, 2026
Pyruvate Kinase Activation in the Management of Thalassemia and Sickle Cell Disease.

|Mar 20, 2026
Patient-Reported Outcomes With Luspatercept Through 5 Years of Treatment in Patients With Non-Transfusion-Dependent β-Thalassemia Treated in the BEYOND Trial.

Khaled M Musallam, Maria Domenica Cappellini, Antonis Kattamis

|Oct 27, 2025
Achieving clinically meaningful changes in haemoglobin levels in patients with non-transfusion-dependent β-thalassaemia treated with luspatercept: A post hoc analysis of the phase 2 BEYOND trial.

Khaled M Musallam, Ali T Taher, John B Porter

|Oct 03, 2025
Quantifying Morbidity Risk Attributed to Red-Cell Transfusion Volume in Optimally Transfused Patients With β-Thalassemia.

Khaled M Musallam, Angela Vitrano, Alessandro Inzerillo

|Aug 28, 2025
Efficacy and safety of luspatercept in non-transfusion-dependent β-thalassemia: long-term results from the BEYOND study.

Ali T Taher, Vip Viprakasit, Antonis Kattamis

Pageof 6

Frequent Collaborators

13 joint publications

Khaled M Musallam

9 joint publications

Maria Domenica Domenica Cappellini

7 joint publications

Filomena Longo

5 joint publications

Paolo Ricchi